Clinical Trial Update: Intravitreal Aflibercept Injections In The Treatment Of Pattern Dystrophy [NA]

View source ↗

Summary

A clinical trial evaluating intravitreal aflibercept injections for pattern dystrophy of the macula has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pattern Dystrophy of Macula

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Manhattan Eye, Ear & Throat Hospital | Conditions: Pattern Dystrophy of Macula | NA | Status: WITHDRAWN